See retatrutide side effects for the full safety profile
This article examines the scientific evidence, potential mechanisms, clinical applications, and important safety considerations surrounding low-dose GLP-1 therapy for inflammatory conditions
And contrary to some fears that GLP-1 medications might increase the risk of depression and suicidality, as other weight loss drugs have in the past, this study found that these newer medications were linked to a lower risk of suicidal ideation, suicide attempts, and the intention to self-harm
Patients can expect to see significant weight loss within the first three months of beginning Semaglutide GLP-1 treatment, although individual results may vary
Doctors warn that complications can be worse if the drugs are misused, for example, taken to lose a few pounds or bought from unregulated online sellers
Semaglutide focuses on GLP-1 and has been on the market longer, with proven results